✦ LIBER ✦

Devices and the Food and Drug Administration

✍ Scribed by Steven J. Phillips; Rachel S. Phillips

Book ID: 109092901
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 41 KB
Volume: 29
Category: Article
ISSN: 0160-564X
DOI: 10.1111/j.1525-1594.2005.01080.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulation of medical devices by the foo

Regulation of medical devices by the food and drug administration

✍ Michael S. Gluck 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 208 KB

Overview of the 2006 Food and Drug Admin

Overview of the 2006 Food and Drug Administration Circulatory System Devices Panel meeting on drug-eluting stent thrombosis

✍ Tina L. Pinto Slottow; Ron Waksman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract Drug‐eluting stents (DES) seemed likely to mitigate the problem of restenosis and have become the predominant stent deployed during percutaneous coronary intervention (PCI). Sustained concerns about the rate of stent thrombosis (ST), particularly very late ST (>1 year following PCI) led

An introduction to the food and drug adm

An introduction to the food and drug administration and how it evaluates new devices: Establishing safety and efficacy

✍ Mark H. Wholey; Jordan D. Haller 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 698 KB

Results of the Phase I Food and Drug Adm

Results of the Phase I Food and Drug Administration clinical trial of duct-occlud device occlusion of patent ductus arteriosus

✍ John W. Moore; Doreen DiMeglio; Alexander P. Javois; Masato Takahashi; Farhouch 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

A food and drug administration primer

✍ Simon, Lee S. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB 👁 1 views

## 4 \* CFR ϭ Code of Federal Regulations; NDA ϭ New Drug Application.

Food and drug administration involvement

Food and drug administration involvement and approval

✍ David H. Woodbury 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 428 KB

The birth ## MINISYMPOSIUM of a new radiopharmaceutical Several new radiopharmaceuticals for myocardial perfusion imaging have been approved for clinical use in recent years or are presently undergoing clinical testing. The time, effort, and cost involved in the entire process of development of a